Welcome to OCT DACH
NUVISAN has extensive experience with healthy volunteers and special population in early phase studies, offering support for dose calculations, escalation methods, and defining the maximum tolerated dose. We are well-versed in regulatory requirements in Germany, ensuring smooth trials from first-in-human studies to later phases in CDD and multicentric trials in Europe.
With operations performed at our four sites in Neu-Ulm, Grafing, Berlin and Sophia-Antipolis, our unique know-how and state-of-the-art bioanalytical equipment can analyze a wide range of items, i.e small molecules, peptides, proteins, antibodies, hormones. We offer both stand-alone and integrated full-service packages across all phases of development.Contact Us